Increased Thyroid Cancer Risk Not Observed After Use of GLP1 Receptor Agonist
Patients who are predisposed to medullary thyroid cancer should be advised against the use of GLP1 agents.
Patients who are predisposed to medullary thyroid cancer should be advised against the use of GLP1 agents.
Join us for an exciting discussion where expert oncologists in the field of colorectal cancer will deliberate on nuances related to sequencing oral tyrosine kinase…
That year, Hill Day brought about 60 ASCO members to Capitol Hill. This year’s event saw more than 170 members visiting the halls of several…
High-intensity focused ultrasound produced noninferior salvage treatment-free survival vs radical prostatectomy in localized prostate cancer.
Investigators established a fluorescence in situ hybridization assay to measure NECTIN4 copy number variations and found that NECTIN4 amplification was associated with high activity of…
2024 SNO/ASCO Metastases August 8-10, 2024, Denver, CO
HOUSTON ― Cancer survivors and tennis legends Chris Evert and Martina Navratilova participated in a fireside-style chat on Wednesday, May 1 at The University of…
Disrupting Jagged2 signaling reprograms immune cells to fight tumors
Show How This Is Building Me, Ep Camidge and Rimel on the Importance of Cultivating Inclusive Gynecologic Oncology Practices – Apr 15, 2024
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…
The Biden administration has—for the second time—delayed the decision on a proposed FDA rule that would ban menthol cigarettes and all flavors in cigars. To…